| 2023-10-10 |
股东大会：
将于2023-11-08召开股东大会
会议内容 ▼▲
- 1.To adopt the Agreement and Plan of Merger (as it may be amended from time to time, the “Merger Agreement”), dated August 30, 2023, by and among Zevra Therapeutics, Inc., a Delaware corporation (“Zevra”), Aspen Z Merger Sub, Inc., a Delaware corporation and a direct wholly-owned subsidiary of Zevra (“Merger Sub”), and Acer, pursuant to which, upon the satisfaction or waiver of the conditions to the closing set forth in the Merger Agreement, Merger Sub will merge with and into Acer (the “Merger”), with Acer surviving as a wholly-owned subsidiary of Zevra;
2.To adjourn the Acer Special Meeting, if necessary or appropriate, in order to solicit additional proxies if there are insufficient votes to adopt the Merger Agreement at the time of the Acer Special Meeting;
3.To approve, by non-binding, advisory vote, compensation that will or may become payable to Acer’s named executive officers in connection with the Merger.
|
| 2023-08-31 |
复牌提示：
2023-08-31 09:52:45 停牌，复牌日期 2023-08-31 09:57:45
|
| 2023-08-14 |
详情>>
股本变动：
变动后总股本2446.37万股
变动原因 ▼▲
- 原因：
- From March 31, 2023 to June 30, 2023
Exercise of Pre-Funded Warrants
Issuance of common stock, net of issuance costs
|
| 2023-08-14 |
详情>>
业绩披露：
2023年中报每股收益-1.07美元,归母净利润-2437.14万美元,同比去年增长-105.73%
|
| 2023-05-15 |
详情>>
业绩披露：
2023年一季报每股收益-0.77美元,归母净利润-1628.07万美元,同比去年增长-77.37%
|
| 2023-04-14 |
股东大会：
将于2023-05-19召开股东大会
会议内容 ▼▲
- 1.Elect Stephen J. Aselage, Jason Amello, John M. Dunn, Michelle Griffin and Chris Schelling to the Board of Directors to serve until the next annual meeting of stockholders or until their respective successors have been duly elected and qualified;
2.Ratify the appointment of BDO USA, LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023;
3.Transact any other business properly brought before the Annual Meeting and any adjournment or postponement thereof.
|
| 2023-03-27 |
详情>>
业绩披露：
2022年年报每股收益-1.66美元,归母净利润-2623.73万美元,同比去年增长-70.66%
|
| 2022-11-14 |
详情>>
业绩披露：
2022年三季报(累计)每股收益-1.11美元,归母净利润-1685.3万美元,同比去年增长-53.86%
|
| 2022-11-14 |
详情>>
业绩披露：
2022年中报每股收益-0.8美元,归母净利润-1184.6万美元,同比去年增长-54.24%
|
| 2022-05-16 |
详情>>
业绩披露：
2022年一季报每股收益-0.64美元,归母净利润-917.9万美元,同比去年增长-506.61%
|
| 2022-04-15 |
股东大会：
将于2022-05-20召开股东大会
会议内容 ▼▲
- 1.Elect Stephen J. Aselage, Jason Amello, John M. Dunn, Michelle Griffin and Chris Schelling to the Board of Directors to serve until the next annual meeting of stockholders or until their respective successors have been duly elected and qualified;
2.Approve, on a non-binding advisory basis, the compensation of our Named Executive Officers;
3.Ratify the appointment of BDO USA, LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2022;
4.Transact any other business properly brought before the Annual Meeting and any adjournment or postponement thereof.
|
| 2022-03-02 |
详情>>
业绩披露：
2021年年报每股收益-1.08美元,归母净利润-1537.4万美元,同比去年增长32.82%
|
| 2021-11-19 |
详情>>
业绩披露：
2021年中报每股收益-0.54美元,归母净利润-768.03万美元,同比去年增长28.35%
|
| 2021-11-19 |
详情>>
业绩披露：
2021年三季报(累计)每股收益-0.77美元,归母净利润-1095.34万美元,同比去年增长34.21%
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-05-17 |
详情>>
业绩披露：
2021年一季报每股收益-0.11美元,归母净利润-151.32万美元,同比去年增长69.42%
|
| 2021-04-16 |
股东大会：
将于2021-05-21召开股东大会
会议内容 ▼▲
- 1.Elect Stephen J. Aselage, Jason Amello, John M. Dunn, Michelle Griffin and Chris Schelling to the Board of Directors to serve until the next annual meeting of stockholders or until their respective successors have been duly elected and qualified
2.Ratify the appointment of BDO USA, LLP as our independent auditors for the fiscal year ending December 31, 2021;
3.Transact any other business properly brought before the Annual Meeting and any adjournment or postponement thereof.
|
| 2020-10-14 |
股东大会：
将于2020-11-19召开股东大会
会议内容 ▼▲
- 1.Elect Stephen J. Aselage, Jason Amello, John M. Dunn, Michelle Griffin, and Chris Schelling to the Board of Directors to serve until the next annual meeting of stockholders or until their respective successors have been duly elected and qualified;
2.Ratify the appointment of BDO USA, LLP as our independent auditors for the fiscal year ending December 31, 2020;
3.Transact any other business properly brought before the Annual Meeting and any adjournment or postponement thereof.
|
| 2019-04-12 |
股东大会：
将于2019-05-17召开股东大会
会议内容 ▼▲
- 1.Elect Stephen J. Aselage, Jason Amello, John M. Dunn, Michelle Griffin, and Chris Schelling to the Board of Directors to serve until the next annual meeting of stockholders or until their respective successors have been duly elected and qualified;
2.Approve, on a non-binding advisory basis, the compensation of our named executive officers;
3.Approve, on a non-binding advisory basis, the frequency of holding an advisory vote on named executive officer compensation;
4.Ratify the appointment of BDO USA, LLP as our independent auditors for the fiscal year ending December 31, 2019;
5.Transact any other business properly brought before the Annual Meeting and any adjournment or postponement thereof.
|
| 2018-04-09 |
股东大会：
将于2018-05-14召开股东大会
会议内容 ▼▲
- 1. Elect Stephen J. Aselage, Jason Amello, Hubert Birner, Ph.D., MBA, John M. Dunn, Michelle Griffin, Luc Marengere, Ph.D., and Chris Schelling to the Board of Directors to serve until the next annual meeting of shareholders or until their respective successors have been duly elected and qualified;
2. Approve certain proposed provisions of the proposed certificate of incorporation under Delaware law in connection with the Reincorporation as set forth below:
2A. Approve a provision to permit stockholder action only at a duly called meeting and to prohibit action by written consent of stockholders;
2B. Approve a provision to eliminate the ability of stockholders to call a special meeting of stockholders;
2C. Approve a provision to provide for the supermajority voting in connection with future amendments to certain provisions of the certificate of incorporation;
2D. Approve a provision to provide for the supermajority voting in connection with future amendments to certain provisions of the bylaws;
2E. Approve a provision to provide that the Court of Chancery of the State of Delaware will be the exclusive forum for certain legal actions;
3. Approve the reincorporation of Acer Therapeutics Inc. from a Texas corporation to a Delaware corporation (the “Reincorporation”);
4. Approve the Acer Therapeutics Inc. 2018 Stock Incentive Plan;
5. Ratify the appointment of Wolf & Company, P.C. as our independent auditors for the fiscal year ending December 31, 2018;
6. Transact any other business properly brought before the Annual Meeting and any adjournment or postponement thereof.
|
| 2017-09-20 |
详情>>
拆分方案：
每10355527.0000合并分成1000000.0000股
|
| 2017-08-09 |
股东大会：
将于2017-09-19召开股东大会
|
| 2016-04-11 |
股东大会：
将于2016-05-16召开股东大会
会议内容 ▼▲
- 1.Elect Timothy C. Barabe, Hans-Peter Hartung, M.D., Gail J. Maderis, Michael S. Richman, Scott B. Seaman and Neil K. Warma to the Board of Directors to serve until the next annual meeting of shareholders or until their respective successors have been duly elected and qualified;
2.Approve the Opexa Therapeutics, Inc. Amended and Restated 2010 Stock Incentive Plan;
3.Hold an advisory “say-on-pay” vote on the compensation of our Named Executive Officers;
4.Ratify the appointment of MaloneBailey, LLP as our independent auditors for the fiscal year ending December 31, 2016;
5.Transact any other business properly brought before the Annual Meeting and any adjournment or postponement thereof.
|
| 2015-11-10 |
详情>>
拆分方案：
每8.0000合并分成1.0000股
|
| 2015-07-23 |
股东大会：
将于2015-08-28召开股东大会
会议内容 ▼▲
- 1. Elect Timothy C. Barabe, Hans-Peter Hartung, M.D., Gail J. Maderis, Michael S. Richman, Scott B. Seaman and Neil K. Warma to the Board of Directors to serve until the next annual meeting of shareholders or until their respective successors have been duly elected and qualified;
2. Approve an amendment to the Company’s Restated Certificate of Formation to increase the number of authorized shares of the Company’s common stock from 100 million to 150 million;
3. Approve an amendment to the Company’s Restated Certificate of Formation to effect a reverse stock split of the Company’s common stock, as determined by our Board of Directors in its discretion, of a ratio of not less than 1-for-4 and not more than 1-for-8;
4. Ratify the appointment of MaloneBailey, LLP as our independent auditors for the fiscal year ending December 31, 2015;
5. Transact any other business properly brought before the Annual Meeting and any adjournment or postponement thereof.
|
| 2015-03-30 |
详情>>
内部人交易：
BARABE TIMOTHY C等共交易2笔
|